Aardvark Therapeutics
$4.12
0
+$0.03+0.73% Today
Statistics
Day High
4.2
Day Low
3.9
52W High
17.94
52W Low
3.35
Volume
47,867
Avg. Volume
293,944
Mkt Cap
89.7M
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
20MayExpected
Expected EPS
-0.888182
Actual EPS
N/A
Financials
-Profit Margin
Unprofitable0Revenue
-41.18MNet Income
Analyst Ratings
$9.80Average Price Target
The highest estimate is 21.00.
From 7 ratings within the last 6 months. This is not an investment recommendation.
From 7 ratings within the last 6 months. This is not an investment recommendation.
Buy 43%
Hold 57%
Sell 0%
People Also Follow
This list is based on the watchlists of people on Stock Events who follow AARD. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Aardvark Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases. Its lead product candidate is the ARD-101, an oral gut-restricted small-molecule agonist of certain targeting bitter taste receptors expressed in the gut lumen that is in Phase III clinical trial for hyperphagia associated with Prader-Willi Syndrome, as well as in Phase II clinical trial for hyperphagia associated with acquired hypothalamic obesity resultant from treatment of craniopharyngioma, including surgery or radiation. It also developing ARD-201, which is in Phase I clinical trial for the treatment of obesity. The company was incorporated in 2017 and is based in San Diego, California.
Show more...
CEO
Dr. Tien-Li Lee M.D.
Employees
22
Country
US
ISIN
US0029421007
Listings
0 Comments
Share your thoughts
FAQ
What is Aardvark Therapeutics stock price today?▼
The current price of AARD is $4.12 USD — it has increased by +0.73% in the past 24 hours. Watch Aardvark Therapeutics stock price performance more closely on the chart.
What is Aardvark Therapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Aardvark Therapeutics stocks are traded under the ticker AARD.
Is Aardvark Therapeutics stock price growing?▼
AARD stock has risen by +16.67% compared to the previous week, the month change is a -25.14% fall, over the last year Aardvark Therapeutics has showed a -56.2% decrease.
What is Aardvark Therapeutics market cap?▼
Today Aardvark Therapeutics has the market capitalization of 89.7M
When is the next Aardvark Therapeutics earnings date?▼
Aardvark Therapeutics is going to release the next earnings report on May 20, 2026.
What were Aardvark Therapeutics earnings last quarter?▼
AARD earnings for the last quarter are -0.81 USD per share, whereas the estimation was -0.83 USD resulting in a +2.09% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Aardvark Therapeutics revenue for the last year?▼
Aardvark Therapeutics revenue for the last year amounts to 0 USD.
What is Aardvark Therapeutics net income for the last year?▼
AARD net income for the last year is -41.18M USD.
How many employees does Aardvark Therapeutics have?▼
As of April 02, 2026, the company has 22 employees.
In which sector is Aardvark Therapeutics located?▼
Aardvark Therapeutics operates in the Health Care sector.
When did Aardvark Therapeutics complete a stock split?▼
The last stock split for Aardvark Therapeutics was on July 21, 2008 with a ratio of 1:2.
Where is Aardvark Therapeutics headquartered?▼
Aardvark Therapeutics is headquartered in San Diego, US.